Mykhailo Mudryk Cleared to Return to Football

Mykhailo Mudryk’s long exile from competitive football is over. After months in limbo and a four-year suspension hanging over his career, the Chelsea winger has been cleared to play again with immediate effect.

The 25-year-old has not featured in a competitive match since November 2024, sidelined by a ban that stemmed from a failed drug test showing a low concentration of meldonium, a prohibited substance, from a sample taken two years ago. That result triggered a heavy sanction and cast a shadow over one of Chelsea’s most expensive signings.

Now the case has been turned on its head by changes to World Anti-Doping Agency (WADA) procedures. Under the updated scientific reporting standards, the same test result today would not even have been flagged.

The Football Association explained the shift in stark terms: “Changes have been made… which, while not retroactive, mean that if Mr Mudryk's sample was collected today, the concentration of meldonium in the sample would not have been reported and no anti-doping rule violations would have resulted.”

Mudryk had lodged an appeal with the Court of Arbitration for Sport (CAS), fighting the four-year suspension that threatened to cut deep into his prime. That appeal has now been resolved through an agreement between the player, the FA and WADA.

“Further to that development and to other circumstances of the case, the FA and Mr Mudryk have now – with the agreement of WADA – resolved the appeal proceedings,” the FA said.

There was a key condition. As part of the settlement, Mudryk accepted that he had committed the Anti-Doping Rule Violations (ADRVs) originally charged. In return, the period of ineligibility was fixed at the time he has already spent out of the game.

“As a part of the agreement, Mr Mudryk accepted that he had committed the ADRVs charged and acceded to a period of ineligibility equal to the time served at the date of the agreement. Mr Mudryk is no longer ineligible and may return to competition with immediate effect.”

For Chelsea, who paid £88m to prise him from Shakhtar Donetsk in January 2023, the decision lifts a significant cloud. The club moved quickly to frame the outcome around the evolution of anti-doping science.

In a statement, Chelsea said: “We welcome the acknowledgement that advances in the applicable scientific reporting standards for more reliable testing mean that, had Misha's sample been analysed under today's technical requirements, it would not have been reported as a positive test and no anti-doping rule violation would have resulted. That is an important part of the context surrounding the agreed resolution and allows everyone involved to move forward.”

The winger now steps back into a very different Chelsea from the one he left in November. New faces, new pressure, same price tag. The ban is gone. The scrutiny will not be.